SeekingAlpha · Aug 24, 2026
Alpha Teknova: Ample Manufacturing Capacity At A High Premium
Alpha Teknova's modular platform lets customers progress from research reagents into larger custom GMP orders. Read why TKNO stock is a Hold.
TK
NASDAQ · TKNO
Alpha Teknova, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$7.31
Down-$0.20 (-2.67%)
Updated Aug 28, 2026, 5:18 PM
SID Score
6.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 262.29M
- P/E ratio
- -14.39
- Dividend yield
- 0.00%
- 52-week range
- $1.91 – $7.84
- Volume
- 174.04K
- Avg. volume
- 238.53K
Price performance
TKNO price history
1M range · 21 trading sessions · Daily adjusted prices
TKNO closed at $7.31 after 21 trading sessions, up 44.75% for the selected period.
- Last close
- $7.31
- Period change
- +44.75%
- Period low
- $5.00
- Period high
- $7.46
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $7.20 | $7.48 | $7.19 | $7.31 | 174.04K |
| Aug 26, 2026 | $7.38 | $7.50 | $7.08 | $7.22 | 190.13K |
| Aug 25, 2026 | $7.34 | $7.51 | $7.21 | $7.46 | 162.17K |
| Aug 24, 2026 | $7.38 | $7.38 | $7.05 | $7.34 | 180.06K |
| Aug 21, 2026 | $7.08 | $7.45 | $6.85 | $7.36 | 220.46K |
| Aug 20, 2026 | $7.13 | $7.30 | $6.78 | $7.00 | 336.21K |
| Aug 19, 2026 | $6.96 | $7.40 | $6.86 | $7.21 | 315.41K |
| Aug 18, 2026 | $7.13 | $7.4057 | $6.65 | $6.81 | 402.87K |
| Aug 17, 2026 | $7.26 | $7.68 | $7.07 | $7.22 | 460.03K |
| Aug 14, 2026 | $7.50 | $7.5638 | $6.61 | $7.29 | 553.39K |
| Aug 13, 2026 | $7.37 | $7.84 | $7.35 | $7.38 | 849.42K |
| Aug 12, 2026 | $6.96 | $7.435 | $6.675 | $7.39 | 359.9K |
| Aug 11, 2026 | $7.11 | $7.24 | $6.69 | $7.04 | 376.6K |
| Aug 10, 2026 | $6.48 | $6.92 | $6.29 | $6.72 | 175.65K |
| Aug 7, 2026 | $6.53 | $6.64 | $6.2334 | $6.46 | 151.45K |
| Aug 6, 2026 | $5.71 | $6.64 | $5.29 | $6.53 | 384.14K |
| Aug 5, 2026 | $5.63 | $5.70 | $5.46 | $5.61 | 128.97K |
| Aug 4, 2026 | $5.33 | $5.80 | $5.1379 | $5.52 | 157.9K |
| Aug 3, 2026 | $5.03 | $5.39 | $4.935 | $5.30 | 127.48K |
| Jul 31, 2026 | $5.06 | $5.095 | $4.7879 | $5.00 | 47.05K |
| Jul 30, 2026 | $5.00 | $5.135 | $4.975 | $5.05 | 79.27K |
Latest TKNO news
The latest Smart Investors Daily articles mentioning TKNO.
Stock researchCompany · Overview
TKNO research
Overview
Company profile and research snapshot.
Company profile
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $9.18
- Implied upside
- —
- Analysts
- 12
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 11, 2026 | BTIG | Buy | — |
| Aug 5, 2026 | Roth Capital | Buy | — |
| Jul 10, 2024 | Stephens & Co. | Overweight | — |
| May 14, 2024 | Stephens & Co. | Overweight | — |
| Mar 12, 2024 | BTIG | Neutral | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 11, 2026
BTIG Upgrades Alpha Teknova to Buy, Announces $8 Price Target
BTIG analyst Mark Massaro upgrades Alpha Teknova (NASDAQ:TKNO) from Neutral to Buy and announces $8 price target.
SeekingAlpha · Aug 9, 2026
Alpha Teknova, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-09. The following slide deck was published by Alpha Teknova, Inc.
Yahoo · Aug 6, 2026
Alpha Teknova Q2 Earnings Call Highlights
Alpha Teknova (NASDAQ:TKNO) reported second-quarter revenue growth of 18% from a year earlier, surpassing $12 million for its highest quarterly revenue in the company’s 30-year history. The company raised its full-year revenue outlook, citing first-half performance and confidence in the second half
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
